We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

3 hedge funds and large institutions have $27.8K invested in Immunogen Inc in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 322 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 327 → 3 (-324)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 322

100% less funds holding in top 10

Funds holding in top 10: 35 → 0 (-35)

100% less capital invested

Capital invested by funds: $7.54B → $27.8K (-$7.54B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-324
Holders Change %
-99.08%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-35
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
322
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MG
Mather Group
Illinois
+$1.84K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$755M
2
RCM
RA Capital Management
Massachusetts
-$704M
3
BlackRock
BlackRock
New York
-$647M
4
RG
Redmile Group
California
-$487M
5
Janus Henderson Group
Janus Henderson Group
-$327M

IMGN Hedge Fund Activity: Q1 2024 in Review

3 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2024, worth a combined $27.8K — down 100% from $7.54B a quarter earlier.

Sellers outnumbered buyers: 322 funds closed out of IMGN and 1 opened new positions — a net loss of 321 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Mather Group, opening a new position worth an estimated $1.84K. The largest seller was Vanguard Group, exiting entirely with an estimated $755M sold.

  • 3 institutional investors held Immunogen Inc (IMGN) as of Q1 2024, down from 327 in Q4 2023.
  • Funds reported $27.8K of Immunogen Inc stock for Q1 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Immunogen Inc positions in Q1 2024 and 322 closed out, a net change of -321 holders.
  • The largest Immunogen Inc buyer in Q1 2024 was Mather Group, an estimated $1.84K added.
  • The largest Immunogen Inc seller in Q1 2024 was Vanguard Group, an estimated $755M sold.

Based on aggregated 13F filings for Q1 2024.